Search - tctmd.com

Displaying 501 - 520 of 520

Sort: Relevancy | Date

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Yael L. Maxwell

October 13, 2011

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Daily News

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

September 21, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Industry News

FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US

July 20, 2011

News Daily News

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

June 15, 2011

News Daily News

Canada Approves Ticagrelor in ACS Patients

June 02, 2011

News Industry News

Health Canada approves BRILINTA (ticagrelor tablets)

June 01, 2011

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Daily News

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

L.A. McKeown

March 29, 2011

News Daily News

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

Caitlin E. Cox

January 25, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

News Daily News

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

L.A. McKeown

January 03, 2011

News Daily News

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Kim Dalton

August 30, 2009

Advertisement

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Ticagrelor Gains FDA Approval for Use in ACS

FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

Canada Approves Ticagrelor in ACS Patients

Health Canada approves BRILINTA (ticagrelor tablets)

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content